1.4000
-0.0400
(-2.78%)
At close: April 11 at 4:10:17 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
1,746,200
1,746,200
1,706,900
2,336,200
1,900,700
Cost of Revenue
224,300
224,300
223,700
316,700
270,600
Gross Profit
1,521,900
1,521,900
1,483,200
2,019,500
1,630,100
Operating Expense
1,456,400
1,456,400
1,385,100
1,531,600
1,388,200
Operating Income
65,500
65,500
98,100
487,900
241,900
Net Non Operating Interest Income Expense
-70,800
-70,800
-62,300
-50,500
-87,600
Other Income Expense
-644,800
-644,800
-433,100
-20,500
13,500
Pretax Income
-650,100
-650,100
-397,300
416,900
167,800
Tax Provision
-14,100
-14,100
-17,300
122,900
101,500
Net Income Common Stockholders
-645,800
-645,800
-367,800
307,900
43,700
Basic EPS
-0.98
-0.98
-0.60
0.48
0.06
Diluted EPS
-0.98
-0.98
-0.60
0.48
0.06
Basic Average Shares
659,760
659,760
615,565.8900
630,460.3210
668,573.6850
Diluted Average Shares
659,760
659,760
615,565.8900
630,460.3210
668,573.6850
Net Income from Continuing & Discontinued Operation
-645,800
-645,800
-367,800
307,900
43,700
Normalized Income
-37,958.4679
-37,958.4679
5,260.5084
294,000
66,300
Interest Expense
30,000
30,000
28,600
15,500
53,600
Net Interest Income
-70,800
-70,800
-62,300
-50,500
-87,600
EBIT
-620,100
-620,100
-368,700
432,400
221,400
EBITDA
-338,900
-338,900
-91,500
710,900
468,700
Reconciled Cost of Revenue
224,300
224,300
223,700
316,700
270,600
Reconciled Depreciation
281,200
281,200
277,200
278,500
247,300
Net Income from Continuing Operation Net Minority Interest
-636,000
-636,000
-380,000
294,000
66,300
Total Unusual Items Excluding Goodwill
-611,300
-611,300
-402,800
--
--
Total Unusual Items
-611,300
-611,300
-402,800
--
--
Normalized EBITDA
272,400
272,400
311,300
710,900
468,700
Tax Rate for Calcs
0
0
0
0.0003
0.0003
Tax Effect of Unusual Items
-13,258.4679
-13,258.4679
-17,539.4916
--
--
6/30/2021 - 7/31/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACL.AX Australian Clinical Labs Limited
2.9700
-2.30%
SHL.AX Sonic Healthcare Limited
24.80
-1.59%
IDX.AX Integral Diagnostics Limited
2.2600
-0.44%
MVF.AX Monash IVF Group Limited
0.6900
-35.81%
WFL.AX Wellfully Limited
0.0030
0.00%
CTE.AX Cryosite Limited
0.7950
0.00%
PEB.AX Pacific Edge Limited
0.1150
+9.52%
GTG.AX Genetic Technologies Limited
0.0390
0.00%
MAP.AX Microba Life Sciences Limited
0.1950
+11.43%
GSS.AX Genetic Signatures Limited
0.3750
-7.41%